Targeting IL-1β signaling reduces cardiovascular risk in atherosclerotic patients45 and AIM2 has recently been identified as an essential mediator of atherosclerosis driven by clonal hematopoiesis induced by the common Jak2V617F mutation.8 The gene discussed is AIM2; the disease is atherosclerosis.